Legend Biotech (LEGN) Income from Continuing Operations: 2018-2024
Historic Income from Continuing Operations for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to -$177.0 million.
- Legend Biotech's Income from Continuing Operations rose 66.98% to -$38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$219.5 million, marking a year-over-year increase of 35.59%. This contributed to the annual value of -$177.0 million for FY2024, which is 65.84% up from last year.
- As of FY2024, Legend Biotech's Income from Continuing Operations stood at -$177.0 million, which was up 65.84% from -$518.2 million recorded in FY2023.
- In the past 5 years, Legend Biotech's Income from Continuing Operations ranged from a high of -$177.0 million in FY2024 and a low of -$518.2 million during FY2023.
- Over the past 3 years, Legend Biotech's median Income from Continuing Operations value was -$446.3 million (recorded in 2022), while the average stood at -$380.5 million.
- As far as peak fluctuations go, Legend Biotech's Income from Continuing Operations crashed by 162.20% in 2020, and later skyrocketed by 65.84% in 2024.
- Over the past 5 years, Legend Biotech's Income from Continuing Operations (Yearly) stood at -$266.4 million in 2020, then tumbled by 51.51% to -$403.6 million in 2021, then dropped by 10.60% to -$446.3 million in 2022, then dropped by 16.10% to -$518.2 million in 2023, then skyrocketed by 65.84% to -$177.0 million in 2024.